G
Galal Yahya
Researcher at Zagazig University
Publications - 48
Citations - 527
Galal Yahya is an academic researcher from Zagazig University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 7, co-authored 24 publications receiving 146 citations. Previous affiliations of Galal Yahya include Kaiserslautern University of Technology & Spanish National Research Council.
Papers
More filters
Journal ArticleDOI
A Whi7-Anchored Loop Controls the G1 Cdk-Cyclin Complex at Start
TL;DR: It is demonstrated that the Cln3 cyclin and Whi7 act in a positive feedback loop to release the G1 Cdk-cyclin complex and trigger Start once a critical size has been reached, thus uncovering a key nonlinear mechanism at the earliest known events of cell-cycle entry.
Journal ArticleDOI
In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes.
Moataz A. Shaldam,Galal Yahya,Galal Yahya,Nashwa H Mohamed,Mohamed M. Abdel-Daim,Mohamed M. Abdel-Daim,Yahya Al Naggar,Yahya Al Naggar +7 more
TL;DR: By molecular docking, the profound binding affinity of 14 selected phenolics and terpenes present in honey and propolis (bees glue) are revealed against the main protease (Msuppro/sup) and RNA dependent RNA polymerase (RdRp) enzymes of the novel 2019-nCoV coronavirus
Journal ArticleDOI
Fighting against the second wave of COVID-19: Can honeybee products help protect against the pandemic?
Yahya Al Naggar,Yahya Al Naggar,John P. Giesy,Mohamed M. Abdel-Daim,Mohamed M. Abdel-Daim,Mohammad Javed Ansari,Saad N. Al-Kahtani,Galal Yahya,Galal Yahya +8 more
TL;DR: In this paper, promising effects of various bee products against the emerging pandemic COVID-19 are discussed, products of honey bees that contain mixtures of potentially active chemicals, possess unique properties that might help to protect, fight, and alleviate symptoms of COVID19 infection.
Posted ContentDOI
In Silico Screening of Potent Bioactive Compounds from Honey Bee Products Against COVID-19 Target Enzymes
TL;DR: It is revealed by molecular docking the profound binding affinity of 14 selected phenolics and terpenes present in honey and propolis against the main protease (Mpro) and RNA dependent RNA polymerase (RdRp) enzymes of the novel 2019-nCoV coronavirus.
Journal ArticleDOI
A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition.
Sameh Saber,Eslam E. Abd El-Fattah,Galal Yahya,Naglaa A. Gobba,Abdalkareem Omar Maghmomeh,Ahmed E. Khodir,Ahmed A.E. Mourad,Ahmed S Saad,Hager G Mohammed,Nehal A Nouh,Ahmed Shata,Ahmed Shata,Noha A. Amin,Magdy Abou El-Rous,Samuel Girgis,Eman El-Ahwany,Eman M. Khalaf,Attalla F. El-kott,Attalla F. El-kott,Ahmed M. El-Baz +19 more
TL;DR: In this paper, the authors investigated the mechanisms underlying the coloprotective effects of rosuvastatin and Lactobacillus and their combined therapy on dextran sodium sulfate (DSS)-induced colitis in high-fat diet (HFD)-fed rats.